In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Bob Li, MD, PhD, MPH
First-Ever KRAS Inhibitor Gets Accelerated Approval for Non-Small Cell Lung Cancer

Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Tumor mutation model
Finding
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
MSK scientist Britta Weigelt and MSK physician-scientist Sarah Kim
New Progress Using Liquid Biopsies to Analyze cfDNA for Endometrial and Cervical Cancers

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
In the Lab
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread

Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
electron micrograph of a natural killer cell
In the Lab
Drugs That Stall — But Don’t Kill — Cancer Cells Are an Untapped Resource, Study Suggests

A drug combination that halts tumor cell division can stir the immune system into taking action.
Dr. Prasad Adusumilli sits at a computer. A patient’s face and a chest image are on the screen.
Feature
MSK Offers Second Opinions for Cancer Diagnosis: 9 Things Patients Should Know

Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
MSK Research Led to FDA Approvals for Cancer Drugs in 2024

The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
MSK surgeons gathered around a robot used for cancer surgery
Q&A
Reality Check: Should People with Cancer Avoid Robotic Surgery?

Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.
Gloved hands hold several test tubes of blood with a piece of lab equipment in the background
Liquid Biopsies and Other Blood Tests for Cancer: What You Should Know 

Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.